Detection and cloning of potent transforming gene(s) from chewing tobacco-related human oral carcinomas
Related Experiment Videos
D Saranath1, L T Bhoite, M G Deo
1Cell and Developmental Pathology Division, Tata Memorial Centre, Parel, Bombay, India.
Abstract:
High molecular weight DNA isolated from 14 primary tumour tissues of human oral carcinoma patients was analysed for transforming activity by NIH3T3 co-transfection assay using pSV2neo gene as a selectable marker, followed by nude mouse tumorigenicity assay. Ten of the patient tumour tissues demonstrated molecular lesions in myc, ras or/and EGF-R genes, whereas 4 patients did not show tumour associated aberrations in these oncogenes. The G418-resistant transfected cells from 12 of 14 individual patients demonstrated transforming potential by colony formation in soft agar and tumour induction in nude mice within 25-80 days. DNAs from the transfected cells, consequent nude mice tumours and corresponding cell lines, contained human Alu sequences. Southern blot hybridisation with ras, myc, EGF-R oncogenes demonstrated the presence of human H-ras oncogene in one of the 12 sets of nude mice tumours. In contrast, DNA from the other 11 sets of nude mice tumours indicated absence of c-myc, N-myc, L-myc, H-ras, K-ras, N-ras and EGF-R genes on Southern analysis. Further, DNAs from five first cycle tumorigenic transformants were subjected to a second cycle of transfection, and induced tumours in nude mice with a shorter latency period of 21-50 days. The secondary transformants contained discrete human Alu sequences; however, the DNA did not hybridise with myc/ras/EGF-R probes. A genomic library was constructed from a second cycle nude mice tumour, using EMBL-3 as the vector. Four human Alu sequence positive clones were isolated on screening 2 x 10(5) plaques, and one of the recombinant clones subjected to fine restriction mapping using 16 restriction enzymes. The lack of association of the nude mice tumour DNA with myc/ras/EGF-R showing aberrations in the primary human tumour, implies activation of an alternative potent transforming gene(s) in the chewing tobacco-related oral carcinomas in India.
Insights
Transforming genes in oral cancer were investigated using NIH3T3 co-transfection and nude mouse assays. Results suggest alternative oncogenes drive oral carcinomas, independent of common myc, ras, or EGF-R mutations.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Oral carcinoma is a significant health concern, particularly in India, often linked to chewing tobacco.
- Common oncogenes like myc, ras, and EGF-R are frequently implicated in cancer development.
- Understanding the genetic basis of oral cancer is crucial for developing targeted therapies.
Purpose of the Study:
- To analyze the transforming activity of DNA from human oral carcinoma tissues.
- To identify potential oncogenes involved in oral carcinogenesis.
- To investigate the role of alternative transforming genes in chewing tobacco-related oral cancers.
Main Methods:
- High molecular weight DNA from 14 primary oral tumors was analyzed using NIH3T3 co-transfection and nude mouse tumorigenicity assays.
- Southern blot hybridization was employed to detect oncogene aberrations (myc, ras, EGF-R).
- Genomic library construction and screening were performed on secondary tumors to identify novel transforming sequences.
Main Results:
- Twelve of 14 patient tumors exhibited transforming potential in vitro and in vivo.
- While some primary tumors showed mutations in myc, ras, or EGF-R, most secondary tumors lacked these specific oncogene alterations.
- Human Alu sequences were detected in transfected cells and tumors, and a genomic library identified novel clones, suggesting the involvement of uncharacterized transforming genes.
Conclusions:
- The study indicates that oral carcinomas, particularly those related to chewing tobacco, may be driven by potent transforming genes other than the commonly studied myc, ras, and EGF-R.
- Alternative oncogenic pathways are likely activated in oral cancer development.
- Further research is needed to identify and characterize these novel transforming genes.